Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Shot down again
Dear friends, The pharmacueicals industry and the medical establishment has once again shot down a potentially promising treatment by labeling it "ineffective." NIL-A, the first (and probably last) neuroimmunophilin drug has, it seems, gone the same route as GDNF and fetal tissue implants. "No conclusive evidence to say it improves P.D. symptoms" is what they say. When the truth of the matter is, the people responsible for the findings, i.e. the medical and drug community, have too much at stake. Think about it for a minute: why would an industry, supported by over a million people (the numbers as you know are growing daily), all of a sudden offer them a cure, thereby cutting off their means of income, which is pretty substancial. Stem cells will be next, I am sure. If there is no possible way to prove them ineffective, I am sure that research and possible treatment will be outlawed. Call me a pessimist, but do you like apples? I call it a conspiracy. How do you like them apples? Jacob ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:listserv@xxxxxxxxxxxxxxxxxxxx In the body of the message put: signoff parkinsn
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance
